Rex Bionics plc – Announcement of partnership agreement with MAAB

/in ,

20 July 2015, link here. Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheel-chair users, is pleased to announce that it has today signed a new agreement for a partnership in China with MAAB Group, an investment and trading company that specialises in sourcing and introducing innovative […]

Read more

Nexvet and Zenoaq Enter Research and Development Collaboration

/in ,

DUBLIN, Ireland, July 7, 2015 (GLOBE NEWSWIRE) — Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the signing of a research and development agreement with leading Japanese animal health company Zenoaq (Nippon Zenyaku Kogyo Co., Ltd.) to develop a number of therapeutic biologics for companion animals. The biologics will target undisclosed proteins involved […]

Read more

Avita Medical – Data Demonstrating ReCell® Effectiveness in Skin Repigmentation Published in Journal of the American Academy of Dermatology

/in ,

6 July 2015. Link here for ASX announcement. Demonstrates 78% Repigmentation compared to 0% in Control Groups.

Read more

SeaDragon Annual Report 2014-2015

/in ,

30 June 2015. Link here. SeaDragon annual report, including audited financial statements, for the year to 31 March 2015.

Read more

SeaDragon streamlines Board

/in ,

SEA: NZX and Media Release 29 June 2015. Link here. Board reduced to five with focus on supply chain and production; outgoing CEO named Honorary President SeaDragon Limited (NZX:SEA) today announces a number of Director changes as it adds production and supply chain management experience to the Board in preparation for the company’s move into the […]

Read more

SeaDragon raises up to $2.5M with convertible loan

/in ,

9:53am, 24 Jun 2015 SEA: NZX and Media Release 24 June 2015 Link here. SeaDragon raises up to $2.5M with convertible loan; signals capital raising Richard Alderton appointed Interim Chief Executive Officer SeaDragon Limited (NZX:SEA) today announces that one of its cornerstone shareholders, BioScience Managers, has agreed to advance the company up to NZ$2.5 million via […]

Read more

Adherium Receives ISO 13485 Certification

/in ,

June 16, 2015 Link here – Adherium (NZ) Limited (formerly Nexus6) has received ISO 13485 medical device quality management system certification for operations at its New Zealand head office. ISO 13485 is an international quality management standard that covers all aspects of a medical device company’s operations from product development to manufacturing to customer support. It has […]

Read more